Modex Therapeutics is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.
Trademark Applications
Trademark applications show the products and services that Modex Therapeutics is developing and marketing.
Modex Therapeutics doesn't have any recent trademark applications, indicating Modex Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
MODEX Pharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for cancer and infectious diseases
02/09/2023
See all trademarks and details in the Full Report.
Market Share of Modex Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Modex Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Modex Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Modex Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.